🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

ICBME is one of the major biomedical engineering conferences in Asia organised by the Biomedical Engineering Society, Singapore and NUS, and has a long esteemed history dating back to 1983. We are calling for abstracts. Check out our website and speakers: icbme2024.org.

🚨 𝐑𝐞𝐦𝐢𝐧𝐝𝐞𝐫: 𝐒𝐮𝐛𝐦𝐢𝐭 𝐘𝐨𝐮𝐫 𝐀𝐛𝐬𝐭𝐫𝐚𝐜𝐭𝐬 by 30 July 2024! The 18th International Conference on Biomedical Engineering is happening in December, and we don't want you to miss out. icbme2024.org/call-for-abstr…

Check out our plenary and keynote speakers: icbme2024.org/speakers/ Don't miss this opportunity to be part of a leading conference in biomedical engineering. Submit your abstract today and join us in advancing healthcare and medical technology!

📢 Hot off the press! CAFs are major regulators of the immune tumor microenvironment. In our new review we dissect a fascinating aspect of this regulation: CAF-induced physical constraints controlling T cell state and localization in solid tumours nature.com/articles/s4156…

🙌 Happy to share our work leveraging micropatterning to generate cancer-associated fibroblast heterogeneity! Here, at Acta Biomaterialia ddec1-0-en-ctp.trendmicro.com/wis/clicktime/…

Thankful that my group's work is featured in The Straits Times! straitstimes.com/singapore/sing… Check out: advanced.onlinelibrary.wiley.com/doi/10.1002/ad… NUSBME NUS Advanced Portfolio News

Bioengineered tumor model offers new tool in fight against peritoneal cancers, via EurekAlert!! eurekalert.org/news-releases/…

Researchers from NUS and NCCS have developed a hydrogel that enables lab testing of drugs on live abdominal cancer samples. The research could lead to more personalised treatment options for peritoneal metastases, an advanced stage for abdominal cancers. straitstimes.com/singapore/sing…

Researchers from NUS and NCCS have developed a hydrogel that enables lab testing of drugs on live abdominal cancer samples. The research could lead to more personalised treatment options for peritoneal metastases, an advanced stage for abdominal cancers. straitstimes.com/singapore/sing…